A detailed history of Glen Eagle Advisors, LLC transactions in Tilray Brands, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 183 shares of TLRY stock, worth $296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
183
Holding current value
$296
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 03, 2024

BUY
$1.6 - $2.48 $292 - $453
183 New
183 $452,000
Q3 2023

Aug 13, 2024

BUY
$1.55 - $3.31 $155 - $331
100 Added 120.48%
183 $437,000
Q3 2022

Aug 13, 2024

SELL
$2.7 - $4.3 $351 - $559
-130 Reduced 61.03%
83 $228,000
Q2 2021

Aug 13, 2024

BUY
$13.68 - $22.34 $1,135 - $1,854
83 Added 63.85%
213 $3.85 Million
Q1 2021

Aug 13, 2024

SELL
$9.0 - $63.91 $477 - $3,387
-53 Reduced 28.96%
130 $2.96 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $990M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.